Katie Wakeham

Summary

Affiliation: MRC/UVRI Uganda Research Unit on AIDS
Country: Uganda

Publications

  1. pmc Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda
    Katie Wakeham
    Medical Research Council, Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda
    J Acquir Immune Defic Syndr 63:228-33. 2013
  2. pmc Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans
    Katie Wakeham
    MRC UVRI Uganda Research Unit on AIDS, PO Box 49, Entebbe, Uganda
    J Antimicrob Chemother 65:316-9. 2010
  3. doi Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda
    Katie Wakeham
    MRC UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    J Palliat Med 13:375-80. 2010
  4. doi Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial
    Rosalind Parkes-Ratanshi
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, UVRI, Entebbe, Uganda
    Lancet Infect Dis 11:933-41. 2011
  5. pmc Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
    Katie Wakeham
    Co infections Studies Programme, Medical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, PO Box 49, Entebbe, Uganda
    Infect Agent Cancer 6:15. 2011
  6. ncbi A pilot study to evaluate aflatoxin exposure in a rural Ugandan population
    Gershim Asiki
    Medical Research Council Uganda Virus Research Institute, Research Unit on AIDS, Entebbe, Uganda
    Trop Med Int Health 19:592-9. 2014

Collaborators

Detail Information

Publications6

  1. pmc Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda
    Katie Wakeham
    Medical Research Council, Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda
    J Acquir Immune Defic Syndr 63:228-33. 2013
    ..Local environmental factors, including other infectious agents, may be key...
  2. pmc Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans
    Katie Wakeham
    MRC UVRI Uganda Research Unit on AIDS, PO Box 49, Entebbe, Uganda
    J Antimicrob Chemother 65:316-9. 2010
    ..Data from retrospective studies have suggested that there may be an interaction between fluconazole and nevirapine, increasing nevirapine concentrations and potentially leading to hepatotoxicity...
  3. doi Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda
    Katie Wakeham
    MRC UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    J Palliat Med 13:375-80. 2010
    ....
  4. doi Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial
    Rosalind Parkes-Ratanshi
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, UVRI, Entebbe, Uganda
    Lancet Infect Dis 11:933-41. 2011
    ..We studied fluconazole as primary prophylaxis against cryptococcal disease in patients awaiting or starting antiretroviral therapy in Uganda...
  5. pmc Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
    Katie Wakeham
    Co infections Studies Programme, Medical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, PO Box 49, Entebbe, Uganda
    Infect Agent Cancer 6:15. 2011
    ..abstract:..
  6. ncbi A pilot study to evaluate aflatoxin exposure in a rural Ugandan population
    Gershim Asiki
    Medical Research Council Uganda Virus Research Institute, Research Unit on AIDS, Entebbe, Uganda
    Trop Med Int Health 19:592-9. 2014
    ..We conducted a pilot study nested within an existing population cohort (the General Population Cohort), to assess exposure to aflatoxin, among people living in rural south-western Uganda...